STL303

DRUG2 trials

Sponsors

Sitala Bio LTD

Conditions

Geographic AtrophyIgAN

Phase 2

A Study in Adults With Geographic Atrophy

Not yet recruitingNCT07606365

Sitala Bio LTDGeographic Atrophy

Start: 2026-06-01End: 2029-08-01Target: 300Updated: 2026-05-28

Safety and Efficacy of STL303 In Patients With Primary Immunoglobulin A (IgA) Nephropathy

RecruitingNCT07606352

Sitala Bio LTDIgAN

Start: 2026-08-04End: 2027-09-01Target: 15Updated: 2026-09-17